With its new CEO installed this week, City Therapeutics is aiming to capitalize on the momentum in signing a new deal. The ...

Character Biosciences, a pioneer in genetics-guided drug discovery and development, today announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative ...

City Therapeutics has inked a new deal with Bausch + Lomb for a gene silencing approach to the eye disorder geographic ...

Whether you exercise regularly and are looking for ways to help with your post-workout recovery, or have back pain due to a less-than-ideal desk setup, it might be time to invest in a targeted ...

Bausch + Lomb has bought US and Canadian rights to a potential biosimilar competitor to Novartis’ Lucentis from Germany’s Stada, as the blockbuster approaches the end of its patent ...

A handheld render that accessory maker Dbrand claims is based on actual specs for the Switch 2. Unless all of these manufacturers are being duped by a single red herring, there’s a good chance ...

A longtime Rochester company could potentially get a different owner. Bausch + Lomb, whose roots in Rochester date back to the 19 th century, confirmed this week that it may explore a potential ...

Anbernic continues to lead in the retro handheld market with its reliable and affordable offerings, and the RG35XX is a prime example. Featuring a 3.5-inch IPS display, this handheld is optimized ...

Bausch + Lomb also said its statement was in response to a request from the Canadian Investment Regulatory Organization (CIRO) after a series of media reports on its likely sale triggered volatility ...

Canada-headquartered Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company, on Thursday confirmed reports that it is exploring a potential sale, acting in response to a ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Bausch Health has about $21 billion in debt, according to data compiled by Bloomberg. Questions about whether the company could remain solvent without Bausch + Lomb have complicated the separation ...